Finding its rhythm: Startup seeks $4M in funding for trailblazing atrial fibrillation treatment
A new Ottawa biotech startup is seeking to raise $4 million to produce groundbreaking treatments aimed at curing one of the most common heart rhythm
Skip to content
David Sali
Dave is OBJ’s senior writer and editor with two decades of experience in the newspaper industry working for a variety of publications from community weeklies to major dailies. He is a four-time award-winning journalist by the Alliance of Area Business Publishers (AABP). He has received awards for best news feature, best scoop and best overall writer among medium-sized business publications.
Flair Airlines pulls out of Ottawa market, citing insufficient demand and ‘high fees’
Low-cost carrier Flair Airlines has officially pulled out of Ottawa Airport, blaming insufficient demand and “high” airport improvement fees charged to passengers. Flair, which began
Get our email newsletters
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.
The Latest
Video
OBJ360
Sponsored
Sponsored
The Ottawa Hospital Foundation’s Campaign to Create Tomorrow
The $500-million fundraising campaign is the largest in our city’s history. It will reshape the future of healthcare in Ottawa and beyond.
EXPERT BLOGS
David Sali
